129 related articles for article (PubMed ID: 15071052)
21. Antifungal susceptibility testing using the E test: comparison with the broth macrodilution technique.
Chen SC; O'Donnell ML; Gordon S; Gilbert GL
J Antimicrob Chemother; 1996 Feb; 37(2):265-73. PubMed ID: 8707736
[TBL] [Abstract][Full Text] [Related]
22. Comparison of a new commercial colorimetric microdilution method with a standard method for in-vitro susceptibility testing of Candida spp. and Cryptococcus neoformans.
Davey KG; Szekely A; Johnson EM; Warnock DW
J Antimicrob Chemother; 1998 Oct; 42(4):439-44. PubMed ID: 9818741
[TBL] [Abstract][Full Text] [Related]
23. Comparison of a spectrophotometric microdilution method with RPMI-2% glucose with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro susceptibility testing of amphotericin B, flucytosine, and fluconazole against Candida albicans.
Rodríguez-Tudela JL; Berenguer J; Martínez-Suárez JV; Sanchez R
Antimicrob Agents Chemother; 1996 Sep; 40(9):1998-2003. PubMed ID: 8878570
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing.
Colombo AL; Barchiesi F; McGough DA; Rinaldi MG
J Clin Microbiol; 1995 Mar; 33(3):535-40. PubMed ID: 7751353
[TBL] [Abstract][Full Text] [Related]
25. Origin of differences in susceptibility of Candida krusei to azole antifungal agents.
Marichal P; Gorrens J; Coene MC; Le Jeune L; Vanden Bossche H
Mycoses; 1995; 38(3-4):111-7. PubMed ID: 7477085
[TBL] [Abstract][Full Text] [Related]
26. In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles.
Barchiesi F; Falconi Di Francesco L; Scalise G
Antimicrob Agents Chemother; 1997 Aug; 41(8):1812-4. PubMed ID: 9257768
[TBL] [Abstract][Full Text] [Related]
27. In vitro activities of voriconazole, fluconazole, itraconazole and amphotericin B against non Candida albicans yeast isolates.
Swinne D; Watelle M; Nolard N
Rev Iberoam Micol; 2005 Mar; 22(1):24-8. PubMed ID: 15813679
[TBL] [Abstract][Full Text] [Related]
28. Determination of Echinocandin MICs for Candida species in less than 8 hours: comparison of the rapid susceptibility assay with the Clinical and Laboratory Standards Institute's broth microdilution assay.
Hazen KC; Dirks D; Masuoka J
J Clin Microbiol; 2009 Dec; 47(12):4043-8. PubMed ID: 19846655
[TBL] [Abstract][Full Text] [Related]
29. Clinical evaluation of the ASTY colorimetric microdilution panel for antifungal susceptibility testing.
Pfaller MA; Arikan S; Lozano-Chiu M; Chen Y; Coffman S; Messer SA; Rennie R; Sand C; Heffner T; Rex JH; Wang J; Yamane N
J Clin Microbiol; 1998 Sep; 36(9):2609-12. PubMed ID: 9705401
[TBL] [Abstract][Full Text] [Related]
30. Comparison of three methods for testing azole susceptibilities of Candida albicans strains isolated sequentially from oral cavities of AIDS patients.
Tortorano AM; Viviani MA; Barchiesi F; Arzeni D; Rigoni AL; Cogliati M; Compagnucci P; Scalise G
J Clin Microbiol; 1998 Jun; 36(6):1578-83. PubMed ID: 9620380
[TBL] [Abstract][Full Text] [Related]
31. Antifungal susceptibility testing of yeasts: evaluation of technical variables for test automation.
Odds FC; Vranckx L; Woestenborghs F
Antimicrob Agents Chemother; 1995 Sep; 39(9):2051-60. PubMed ID: 8540715
[TBL] [Abstract][Full Text] [Related]
32. Cyclic AMP signaling pathway modulates susceptibility of candida species and Saccharomyces cerevisiae to antifungal azoles and other sterol biosynthesis inhibitors.
Jain P; Akula I; Edlind T
Antimicrob Agents Chemother; 2003 Oct; 47(10):3195-201. PubMed ID: 14506030
[TBL] [Abstract][Full Text] [Related]
33. Epidemiology of candidemia in Shiraz, southern Iran: A prospective multicenter study (2016-2018).
Arastehfar A; Yazdanpanah S; Bakhtiari M; Fang W; Pan W; Mahmoudi S; Pakshir K; Daneshnia F; Boekhout T; Ilkit M; Perlin DS; Zomorodian K; Zand F
Med Mycol; 2021 May; 59(5):422-430. PubMed ID: 32692816
[TBL] [Abstract][Full Text] [Related]
34. Antifungal susceptibility of bloodstream yeasts isolated at a public children's hospital in Brazil: comparison of the Etest and the AFST-EUCAST microdilution method.
Matsumoto FE; Dias AL; Melhem MS; Szeszs MW; Auler ME; Ruiz LS; Gonçalves da Silva E; Gandra RF; Paula CR
Can J Microbiol; 2007 Dec; 53(12):1300-6. PubMed ID: 18059562
[TBL] [Abstract][Full Text] [Related]
35. Fluconazole susceptibilities of bloodstream Candida sp. isolates as determined by National Committee for Clinical Laboratory Standards method M27-A and two other methods.
Cantón E; Pemán J; Carrillo-Muñoz A; Orero A; Ubeda P; Viudes A; Gobernado M
J Clin Microbiol; 1999 Jul; 37(7):2197-200. PubMed ID: 10364585
[TBL] [Abstract][Full Text] [Related]
36. Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.
Warnock DW; Johnson EM; Rogers TR
J Antimicrob Chemother; 1998 Sep; 42(3):321-31. PubMed ID: 9786472
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the fungitest kit by using strains from human immunodeficiency virus-infected patients: study of azole drug susceptibility.
Witthuhn F; Toubas D; Béguinot I; Aubert D; Rouger C; Remy G; Pinon JM
J Clin Microbiol; 1999 Mar; 37(3):864-6. PubMed ID: 9986878
[TBL] [Abstract][Full Text] [Related]
38. Clinical applicability of antifungal susceptibility testing on non-Candida albicans species in hospitalized patients.
Wong-Beringera A; Hindler J; Brankovic L; Muehlbauer L; Steele-Moore L
Diagn Microbiol Infect Dis; 2001 Jan; 39(1):25-31. PubMed ID: 11173188
[TBL] [Abstract][Full Text] [Related]
39. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
Panizo MM; Reviákina V; Dolande M; Selgrad S
Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308
[TBL] [Abstract][Full Text] [Related]
40. [Multisite evaluation of a colorimetric broth microdilution antifungal susceptibility testing].
Yamane N; Igari J
Rinsho Byori; 1997 Feb; 45(2):190-9. PubMed ID: 9121005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
